StringSHA-1SHA-256
kIcd9b7dd77c5f25275284e2da031249447962a88e5069914757d443f26633165723ff61e287f5440adfee1c1d2f45988cd18b8d33c67
kIcd9a9d2837bc2a03ef950c4d9009537643236edda2e81df4b4b4537acef27efae69e2ba053793eb3d1f173b547a64d48596a6a9d9a8b
kIcd9b9f49656be91aab971f65b63647377914af4174d1e207d80451e19fc2bc43c5365ee990aad8c7269766317cad3a07e8461c8e08d5
kIcd9cd8efe8e60680af8ae065e3347a8510e8b1a596d39d56aaa349e34b43c1f89548a98acc1827e67cfc2b953daaaee575b93524af41
kIcd9d265d98bfcc8873c09ee08fc131be39fe4c1b3725c4e2a7dc9c75f4f042a25ad08e33a45795938d17e3e9c0cbeb55be3a6f9eb5b4
kIcd9ecf3f7d53bf6fd62d73f2a61d919d8682e0cb7f935c19be21ffb26779d2ee1c4c138e5787f823edf9d684f75c78d2a658bce1b862
kIcd9fc4a352d8ad4aae8b0f96d4f5ce91147bbbacb9bb5ca25d53d33577e9a9a5735bd1eda37f628256dba59fb48627712d49bb3e4f55
kIcd9g22adec72ea093a12480df67a4fb7b607ef001ae0c8caa6b87ba287182bb805bb8bc28ec07d8e01d4de8995bef36742f4239e8654
kIcd9hbfe064b156b5dcb8294f2ce47a042e32e80b519763a1e1571d6a7e351bd4565da47f55cc3951a4aca4a74af330a46c65e1a33347
kIcd9i7302e7b60e571e2d117f8d57a0986af0ac97af14fa5c00d6ac76c16f5c13ec7c25d41e62eb4fbb451345a503e6c19bd3bfbb294b
kIcd9j86339a125aa4e490e09c19c898853d1e926826d069fedefae47da9929d9252fb3a4b3e1db929fdd336cef72cb9ed8118aa0a7200
kIcd9k2971a88794d17465221725e3c70a63f676da50f8edf4e33a7e7f28916fe8218b7bb30176e5831264790575cde8dc83e56b274c21
kIcd9ldfb82a4dc92c651c10acdf59c09be7d40bc906216536ddbf6b11735c06463337bdaad0a401d6b5a5a0799ab45e2e1c0bfa0c05e6
kIcd9m9c7f8912059826ceed64cb6c1125297116fd6f772373e1516db89557836687334f2250ba8bcf54b71a3c8264ae6ffae1717be768
kIcd9n03e8b937313d707a4464f6bc806ba1f254c983fd69ec93dcf3b5b6d6d02123efba10299d53ee34ab142ea817b15ff3f1e5c0acc7
kIcd9odab18df8ec1bc8cecc652d20c4cc43db927da17510fe757e1a1ff2db143ba3b12397c84bb04cc39ee0d61e76c0f27e1d3d4d9a0c
kIcd9p5461dd2a929090927b6dd85e7470532bf419bdea1422aea1b3115becb56fbb2d5d082cd5520645d63be544560f1c56df39124708
kIcd9q5f9da36d72d8c4c6f347f51aa02e93a14d2a92f2b398ee99b577ef11918dce8cc8b5d5b0b068b405db21d99efe10d34b9b1e2b75
kIcd9r135d8166073a4861a38938179074aa2fcf74e4f37080eb26ac96c665ef34a674f2c88adbf682c31082ceb34b7ceb821c2050d47b
kIcd9sae3d5df42c856c99797e2f165a4000100319eebf44aa0b6256692d6f6418c971c610dcd265da8f27612822adaa9159992dfe5f82
kIcd9t967ca7bbf4cc7e25da65fdebaecda1008253d087964cfe14ef8f1ff9530287760f3e080a149ab42dbd8aaaf485445b95e8be84d9
kIcd9uae075c841776eba1993cf26e3e2660fa820ea2e1df5395cfa85b8911ff2fd6849b91d329c3e335f100dd1b9f0d5037e3028e828d
kIcd9v76269764f017503780d7e981945d70615a6cbc4a7a5383ce3531ee2a7a5e9e61031d250d8e315341a5969c49f020b82ec7cfa41b
kIcd9w2e44c31f76610d73100be6be7c9e7a5da3624e46ae6fd6048a8dc0026952e0e3544e95b85b196567669375e2fadd1b8115967fe0
kIcd9x46a249c4b31e616ebd1508651eb3e478f7947ca0ad6779ab35a14b924118af341be6ac77c3abb24cc663680c22d9f4173ea1b04f
kIcd9y0c5fd1e9558553e92742af812a7474bf7510c05484c85c2693cc96a16c7b169983738a4a5a56c773d7a1590ab8c5f6850ac3bb3d
kIcd9ze4922c32f106663216f19485e76e7ccfcff572999f2809cefba1279687a2d3b6d7fb0ec40e7792536f64cb5319575fa1caed7cec
kIcd9A699464a048375d77be1e5f9c91ea09d67fe3366c7d70b38d44b52b859491faff7b5143e441f8936733b94dccb2fac28b6cdbb432
kIcd9Bdb74829e0d68dd135a0351b50e1fcb8f6f03d311bd337d41adeebdf29f04de1976ecc87de33c2aa9328d10d64b37e9619b9c68c6
kIcd9Cfc63a29edbcfaa5c9b93e6eea3d60b81f8f2874aed0c3e069add8e1dba6d5ddb343dea6857a2ffecd280cce995ab68db192a222e
kIcd9Dd6c587749ebdc66a3b247cb1fe5533d8d6030e583a6c2bf8c876b74f8620fff525ac287c3f55ed6fc177053df0b17a62d79cba61
kIcd9E259cbb3f3ea7b8ef8bd9f6a56835ee28c790ad846310d8c363d617e693509bd39eff21a7dc092e8f76f76d1176c1bc5cfbbaf809
kIcd9F2af40779064e175322b03a4b64735b8264329452c6ddcfcd63bb78343ed0b4874e3748880c47f9346129e2b2bb5a47543661b0db
kIcd9Gf2693f642bae63d8620f25c451963fa66a350e46d1e1a22a1ad870f8e594c4066de4859162db7b5c65823e42365a68be15a8f305
kIcd9H20e9ce279832c23f0acab889ca1c7fb964fb81d45caa97e999f6fe7ebaa1203d9c2555a7b3e14738f3dfc17dd16401f5c09a1c2d
kIcd9I964bea3acdefc20b0d2369bb43061dba70e6a09ff843ef85acae39b547b1575da4251a10f2cc94b136783861b559ba0ae1831cab
kIcd9Jc161430b582adab66252aa1b794f917ec017b7ff6436a84a1af054a9dba8506a07e73bb10e039aabd1d4caa97d50931a8977c1ff
kIcd9Kcd6cd4bdaec5190ee8a92889a7b0ba1a06ebf64b027f6dd777b74612365748d65f9a4014b4a0185afe731be1a607aee5f228df92
kIcd9L68d977cb5b7eea2098541b80f5e1452dbad88838af628b393181c4f4c26b08dfb6c4d7a538080ce518a6b140a024ad637e9292fd
kIcd9Mc6003d0a74bedc68049bba65aac72a669b6a9adada15984f67520916689bc7d82ed8dda36ae313b0caac62b658f37175b0c8c306
kIcd9N8743dfe02fe02fd05d9a40a4e1bc8a3365f337170fa37fb2bc8da2c0f39c7e9bd83c1c65f689419eed6b30f5b0edf569a8cdb172
kIcd9Oe8f0c5e66f65bf0136e39d022ab3139f56fd357209b5f8101ab8787f489e8617f71073c54bd974f4e8f3ad08d9b0450b5028a738
kIcd9Pf8d436a2b6a06e98fa626f91d795f601bc0c045d03644b52d5bffad88c32c485da612d68b87922737ea82fb34ba745c20d020153
kIcd9Q8ea5722b259de946cf4631ed120628381cc13a2a9fa8d383d550924f025ad0dd6590f933ab05a054967241f9eee11e679a94546d
kIcd9Rdc81ae9a3fc18ec7441f01f05c44d6e9b10c01bbd3f2f24691e08b5c12a2ac68fd5098cca616bac5385df65cdaa1ea98ec70e63f
kIcd9S80e0e09a880a690b96724a96644afc59c54b2c0f2decf3e10d39121f8d8719667cefd164bdd1b236b37ab82dc7456e04e8c2b6af
kIcd9T241a63d977be4535c20b64376c294cc31a18ea3cdc964b31ccf23ea0f861742e8c21b11a63df76f21a9f56a73ab03e0166ce87f7
kIcd9Uc1c5b469837b112f450ef4169dfacacfee1689f6268dfea75cdddecad06c139bb416790cc0fac206bcbc8cff57c760dfd346394a
kIcd9V059b5b7d5db5c0b58eca1b31d8cc9680921874658da91fa3c7081faffaad46e6013c4b9d4fd6254822dbfafe2ed6da0d26943d9a
kIcd9W09d99d0510d3d465bf6de0d2e8012f6a6af3d2994bd56df199f358a83244d2e52e0b5bc50cc376407860ca59be42691b465fac12
kIcd9Xa9c81ae51a01fb2bf30cefadb3a04a44cbd9f867ddd9ede9e083e911bcfc01b524bfd1b25ad1226776477c6cb6440961aed2c585
kIcd9Y86622b0629033057dd27927d34293d6fe3f57da19e92efb3b22c60cc0773605000c2f2419024cf42955321dafcf7687dcb658955
kIcd9Z2666960d48fbc3428fc937100b316f3aac3a0e6ef70d09d39bbc5f6f9b51ba0287c5631b0ff051280c9ad52e2d4a820050808ead
kIcd9051a83f2d063a0b14931d727b5650e66be6b22e6f40752d07d0be67e1312a89e6454bb491899d8a64ed34f8b6a25a7b1ab1874980
kIcd917b7a6c0c4434f3c61bc1ee9375d356cc53cfbcbc5b12514381b850d0d244473461afed376eea979162c29045919ec97c4f6eae03
kIcd92c70673e6ffc7377e771421efffd840765e02779ef571da6024fd436c3cf16350937ed51dfcb1d73a0b92f5cf4b66ace07e18444f
kIcd9396cec2a848c413d806be32d49ac48f2bf34034642c48109f994c9363c409eb9fc1671cd6d9344b4a428dd0a1dc9ed224c9b01ca4
kIcd94ce95cf0588358023048296517ef3c1b946225dd3a9947f95c453e6c751111a5c9507405f7d0cabd81e027b35652e24ecc7687c3c
kIcd95e2e95ab0d627b3a56416c91fc4390c3457167646a10ce7a1247937874bef6c3ab9e2dfd874dd0ee68899dd7c9fccdc690b747a9d
kIcd96a4ce8203dc4a8e96a507bd24451a7b12af7f1e5554b473708e9c14f66c76f0b32a294fb76ea53511004459da50e83971db5cffbe
kIcd97e383d69cb103416994181c0015897d1d90207f2375793041970912c8e9ac6aca569aa101c8769baacb39fd63add94cc784d7b440
kIcd989ce9205d21006557eb8a9028d7cae0b39e2aacbcf2e9b991119f3ddd5cc33cca7c019071462c195d287fbfbc5c924a3790041b41
kIcd99f8acfa9bc602aa42898e5d9d343c9293514717bd6af215c2877872526b991bdd42d764580b974c3240eb12aff79d108cb5a233b8